These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SCHEDULE 14A
|
|
NMI Holdings, Inc.
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
5)
|
Total fee paid:
|
|
|
1)
|
Amount previously paid:
|
|
|
2)
|
Form, Schedule, or Registration Statement No.:
|
|
|
3)
|
Date Filed:
|
|
|
1.
|
the election of seven directors to the board of directors to serve until the 2017 Annual Meeting of Stockholders;
|
|
2.
|
the ratification of the appointment of BDO USA, LLP as NMI's independent registered public accounting firm for the year ending December 31, 2016; and
|
|
3.
|
any other matters that properly come before the Annual Meeting.
|
|
ABOUT THE ANNUAL MEETING AND PROXY STATEMENT
|
|
|
ITEM 1 - ELECTION OF DIRECTORS
|
|
|
CORPORATE GOVERNANCE AND BOARD MATTERS
|
|
|
EXECUTIVE OFFICERS
|
|
|
COMPENSATION OF NAMED EXECUTIVE OFFICERS AND DIRECTORS
|
|
|
BENEFICIAL OWNERSHIP OF COMMON STOCK
|
|
|
ITEM 2 - RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
|
|
|
FORM OF PROXY CARD
|
|
|
•
|
possess fundamental qualities of intelligence, honesty, perceptiveness, good judgment, maturity, high ethics and standards, integrity, fairness and responsibility;
|
|
•
|
maintain a genuine interest in the Company and recognize that as a member of the Board he or she is accountable to the stockholders of the Company and not to any particular interest group;
|
|
•
|
have financial services or other relevant industry experience gained through senior management or board of director service;
|
|
•
|
have prior board experience, either as a director of a public company or as both an executive officer of a public company and a director of a privately held company;
|
|
•
|
not serve on more than three other boards of directors of public companies;
|
|
•
|
meet the independence requirements under NASDAQ listing requirements (other than our management directors);
|
|
•
|
have the ability and be willing to spend the time required to function effectively as a director;
|
|
•
|
be compatible and able to work well with other directors and executives in a team effort with a view to a long-term relationship with the Company as a director; and
|
|
•
|
possess independent opinions and be willing to express them in a constructive manner.
|
|
•
|
acting as the primary contact between the Company and the independent directors, undertaking to meet or confer periodically with members of the Company's executive team regarding matters related to the business of the Company;
|
|
•
|
assisting the Chairman of the Board, as necessary with conducting Board meetings;
|
|
•
|
assisting with preparation of agenda items for meetings of the Board and its committees; and
|
|
•
|
such other duties as the Board may from time to time assign to the Lead Director.
|
|
•
|
the integrity of the financial statements of the Company;
|
|
•
|
the independent auditor's qualifications and independence;
|
|
•
|
the performance of the Company's internal audit function and independent auditors;
|
|
•
|
the Company's system of disclosure controls and system of internal controls over financial reporting; and
|
|
•
|
the Company's compliance with legal and regulatory requirements.
|
|
•
|
overseeing our executive compensation program, including approving corporate goals relating to compensation for our CEO and other senior executives and determining the annual compensation of our CEO and other senior executives;
|
|
•
|
reviewing and approving the compensation policy recommended by management with respect to other employees;
|
|
•
|
determining, subject to ratification by our independent directors, the compensation of our independent directors;
|
|
•
|
evaluating the relationship between our risk management practices and our compensation policies and practices applicable to all employees, including our CEO, to consider whether they encourage risk-taking that would be reasonably likely to have a material adverse effect on the Company;
|
|
•
|
reviewing and approving incentive and equity-based compensation plans and grants; and
|
|
•
|
preparing the Compensation Committee Report and reviewing any Compensation Discussion and Analysis included in our proxy statements, to the extent such disclosure is required by SEC rules. These rules are not yet applicable to us because we currently qualify as an emerging growth company under the Jumpstart Our Business Startups Act.
|
|
•
|
identifying individuals qualified to become Board members and recommending to the Board nominees for election for the next annual meeting of stockholders;
|
|
•
|
reviewing the qualifications and independence of the members of the Board and its committees on a regular periodic basis;
|
|
•
|
recommending to the Board corporate governance guidelines and reviewing such guidelines, as well as the Governance and Nominating Committee charter, to confirm that they remain consistent with sound corporate governance practices and with any legal requirements;
|
|
•
|
leading the Board in its annual review of the Board's and its committees' performance; and
|
|
•
|
recommending committee assignments for members of the Board.
|
|
•
|
monitoring the performance of the Company's insured books of business and the principal factors affecting performance;
|
|
•
|
discussing, reviewing and monitoring the Company's mortgage insurance products, including premium rates, underwriting guidelines and returns;
|
|
•
|
reviewing and approving the Company's investment policy and reviewing the performance of the investment portfolio;
|
|
•
|
reviewing the mortgage insurance operating environment, including the state of local and regional housing markets, competitive forces affecting the Company and the Company's relationships with residential mortgage lenders and investors;
|
|
•
|
assisting the Board in its oversight of the Company's enterprise risk management approach, including the significant risk management policies, procedures and processes; and
|
|
•
|
reviewing and approving the Company's director's and officer's liability coverage for adequacy and scope.
|
|
•
|
The Audit Committee oversees and reviews risks associated with financial accounting and reporting, including our system of internal controls, as well as fraud risk, information technology and cybersecurity risk, and major legislative and regulatory developments which could result in material financial risk exposures. In performing this function, the Audit Committee considers information from our independent registered public accounting firm and internal auditors and discusses relevant issues with management and the independent registered public accounting firm. The Audit Committee also reviews any proposed related person transactions to ensure that we do not engage in transactions that would create a conflict of interest that could result in harm to us.
|
|
•
|
The Compensation Committee evaluates the risks and rewards associated with our compensation philosophy and programs.
|
|
•
|
The Governance and Nominating Committee oversees our implementation of sound corporate governance principles and practices. In performing this function, the Governance and Nominating Committee periodically reviews and recommends changes to the Company's Corporate Governance Guidelines and recommends any additional actions related to governance matters that it may deem necessary or advisable from time to time.
|
|
•
|
The Risk Committee assists the Board in its oversight and review of information regarding our enterprise risk management approach and oversees risks related to our mortgage insurance business and investment portfolio.
|
|
•
|
whether the transaction is on terms that are fair and reasonable to the Company and substantially the same as would apply if the other party was not a related party;
|
|
•
|
the size of the transaction and the amount payable to the related party;
|
|
•
|
the nature of the interest of the related party in the transaction;
|
|
•
|
whether the transaction is in the business interests of the Company and in the interests of the Company's stockholders;
|
|
•
|
whether the transaction may involve a conflict of interest or otherwise interfere with the objectivity and independence of the related party; and
|
|
•
|
any other facts and circumstances that the members of the Committee or Chair, as applicable, deem relevant.
|
|
Name and Principal Position
|
Year
|
Salary
|
Bonus
(1)
|
Stock Awards
(2)
|
Option Awards
(3)
|
Non-Equity Incentive Plan Compensation
|
Nonqualified Deferred Compensation Earnings
|
All Other Compensation
(4)
|
Total
|
|
Bradley M. Shuster, Chief Executive Officer
|
2015
|
$600,000
|
$1,110,000
|
$493,700
|
$807,669
|
$—
|
$—
|
$56,672
|
$3,068,041
|
|
2014
|
$600,000
|
$600,000
|
$251,328
|
$753,949
|
$—
|
$—
|
$55,429
|
$2,260,706
|
|
|
2013
|
$585,000
|
$1,458,000
|
$883,350
|
$607,998
|
$—
|
$—
|
$25,600
|
$3,559,948
|
|
|
William J. Leatherberry, General Counsel
|
2015
|
$358,333
|
$453,600
|
$70,550
|
$291,471
|
$—
|
$—
|
$89,028
|
$1,262,982
|
|
|
|
|
|
|
|
|
|
|
|
|
Glenn M. Farrell, Chief Financial Officer
|
2015
|
$375,000
|
$472,500
|
$93,500
|
$263,304
|
$—
|
$—
|
$42,325
|
$1,246,629
|
|
|
|
|
|
|
|
|
|
|
|
|
Claudia J. Merkle, Chief of Insurance Operations
|
2015
|
$358,333
|
$503,600
|
$76,500
|
$263,916
|
$—
|
$—
|
$40,600
|
$1,242,949
|
|
2014
|
$350,000
|
$267,750
|
$117,040
|
$377,720
|
$—
|
$—
|
$41,300
|
$1,153,810
|
|
|
(1)
|
The bonus amounts for each fiscal year presented include each named executive officer's annual incentive bonus that was earned in such year but awarded at the discretion of the Compensation Committee and paid in the subsequent fiscal year. For example, the 2015 bonus amount includes each named executive officer's 2015 annual incentive bonus that was earned in 2015 but awarded and paid in 2016. For Mr. Shuster, the 2013 bonus amount includes $300,000 for each of (i) a GSE Approval bonus, (ii) a bonus for filing a registration statement and (iii) a bonus for the effectiveness of the registration statement, for a total of $900,000. These bonus opportunities were provided for under Mr. Shuster's 2012 employment agreement.
|
|
(2)
|
Represents the grant date fair value of the restricted stock units (RSUs) granted to our named executive officers in the respective fiscal year, calculated in accordance with FASB ASC Topic 718, Compensation-Stock Compensation (ASC Topic 718).
|
|
(3)
|
Represents the grant date fair value of stock options granted to our named executive officers in the respective fiscal year, calculated in accordance with ASC Topic 718. See Note 8, "Share-Based Compensation" of our consolidated financial statements filed with the SEC on Form 10-K for the fiscal year ended December 31, 2015 for an explanation of the assumptions made in valuing these awards.
|
|
(4)
|
The Company includes in the annual compensation of each named executive officer a standardized, fixed cash amount to be used at the discretion of the executive officer, in lieu of individualized perquisite programs. In 2015 and 2014, as applicable, the additional compensation under this program was $38,400 for Mr. Shuster and $30,000 for Messrs. Farrell and Leatherberry and Ms. Merkle. The amounts in this column also include Company matching contributions under the Company's 401(k) plan, as discussed below in "-
Other Compensation Programs and Practices - Retirement Plan
." The amounts in this column for Mr. Leatherberry also include temporary housing allowances paid to him by the Company. The amounts in this column for Messrs. Leatherberry and Farrell also include Company contributions to each executive's health savings account, a tax-advantaged medical savings account, which is an annual benefit available under the medical benefit plans we offer to all of the Company's eligible employees, including our named executive officers.
|
|
•
|
Mr. Shuster's annual base salary and target bonus opportunity will be determined by our Compensation Committee. For 2016, the Compensation Committee has determined that Mr. Shuster's current annual base salary and target bonus opportunity will remain the same as in 2015, at $600,000 for his base salary and $600,000 for his target bonus opportunity, which is conditioned on the attainment of certain corporate and individual performance conditions as determined by the Compensation Committee in its discretion.
|
|
•
|
If the Company reports positive net income for a calendar quarter during the term of his employment agreement, as determined using generally accepted accounting principles (GAAP), Mr. Shuster's salary is subject to a one-time automatic increase by $150,000 on the first day of the calendar quarter next following the calendar quarter in which the Company achieves the net income goal, unless the Company and Mr. Shuster agree otherwise. Further, if the Company reports positive net income, under GAAP, for any calendar quarter during 2016, Mr. Shuster's target bonus opportunity is subject to automatic increase by $150,000. To date, neither of these increases has occurred.
|
|
•
|
Mr. Shuster is eligible for an annual equity grant on terms and conditions no less favorable than those provided to other senior executives of the Company. In connection with the execution of Mr. Shuster's 2015 employment agreement, we granted Mr. Shuster 30,000 RSUs. See "-
Grants of Plan-Based Awards for 2015
."
|
|
•
|
Mr. Shuster will receive employee benefits on a basis no less favorable than those provided to our other senior executives, including participation in the Company's 401(k) plan and executive cash allowance program, as discussed below in "
- Other Compensation Programs and Practices.
"
|
|
•
|
In addition, Mr. Shuster is eligible to receive certain severance benefits, including accelerated vesting of his outstanding equity awards upon certain qualifying terminations of employment and enhanced severance benefits if there is a qualifying termination of employment within two years following a "change in control." When we entered into Mr. Shuster’s December 2015 employment agreement, the multiplier for purposes of calculating post-change in control severance benefits was decreased from three times Mr. Shuster’s salary and target bonus opportunity (as provided under his 2012 agreement), to two times Mr. Shuster’s salary and target bonus opportunity. See below under
"- Potential Payments Upon Termination of Employment or Change in Control"
for a description of the severance benefits that Mr. Shuster would have been eligible to receive as of December 31, 2015.
|
|
Name
|
Grant Date
|
All Other Stock Awards: Number of Shares of Stock or Units (#)
(1)
|
All Other Option Awards: Number of Securities Underlying Options
(2)
|
Exercise or Base price of Option Awards ($/Sh)
|
Grant Date Fair Value of Stock and Option Awards
(3)
|
|
Bradley M. Shuster
|
2/12/2015
|
—
|
263,800
|
$8.50
|
$807,669
|
|
2/12/2015
|
33,800
|
—
|
$—
|
$287,300
|
|
|
12/23/2015
|
30,000
|
—
|
$—
|
$206,400
|
|
|
William J. Leatherberry
|
2/12/2015
|
—
|
95,200
|
$8.50
|
$291,471
|
|
2/12/2015
|
8,300
|
—
|
$—
|
$70,550
|
|
|
Glenn M. Farrell
|
2/12/2015
|
—
|
86,000
|
$8.50
|
$263,304
|
|
2/12/2015
|
11,000
|
—
|
$—
|
$93,500
|
|
|
Claudia J. Merkle
|
2/12/2015
|
|
86,200
|
$8.50
|
$263,916
|
|
2/12/2015
|
9,000
|
—
|
$—
|
$76,500
|
|
|
(1)
|
The 2015 RSU grants vest in 1/3 increments on the first, second and third anniversaries of the grant date.
|
|
(2)
|
The 2015 stock option grants vest in 1/3 increments on the first, second and third anniversaries of the grant date.
|
|
(3)
|
The amounts included in this column reflect the grant date fair value of stock option and RSU awards to our named executive officers in 2015. The grant date fair value was determined in accordance with ASC Topic 718.
|
|
|
|
Option Awards
|
Stock Awards
|
|||||||
|
Name
|
Grant Year
|
Number of Securities Underlying Unexercised Options Exercisable (#)
|
Number of Securities Underlying Unexercised Options Unexercisable (#)
|
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)
|
Option Exercise Price ($)
|
Option Expiration Date
|
Number of Shares or Units of Stock That Have Not Vested (#)
|
Market Value of Shares or Units of Stock That Have Not Vested ($)
|
Equity
Incentive
Plan Awards:
Number of
Unearned
Shares, Units or
Other Rights
That Have Not
Vested (#)
|
Equity
Incentive
Plan Awards:
Market or
Payout Value
of Unearned
Shares, Units or
Other Rights
That Have Not
Vested ($)
(10)
|
|
Bradley M. Shuster
|
2012
|
907,500
|
—
|
—
|
$10.00
|
4/24/2022
|
—
|
—
|
330,000
(5)
|
$2,234,100
|
|
2013
|
88,890
|
44,443
(1)
|
—
|
$11.75
|
2/14/2023
|
—
|
—
|
12,000
(6)
|
$81,240
|
|
|
2014
|
50,566
|
101,134
(2)
|
—
|
$12.32
|
2/12/2024
|
—
|
—
|
13,600
(7)
|
$92,072
|
|
|
2015
|
—
|
263,800
(3)
|
—
|
$8.50
|
2/12/2025
|
—
|
—
|
63,800
(8)
|
$431,926
|
|
|
William J. Leatherberry
|
2014
|
19,616
|
39,234
(4)
|
—
|
$9.45
|
9/10/2024
|
—
|
—
|
5,294
(9)
|
$35,840
|
|
2015
|
—
|
95,200
(3)
|
—
|
$8.50
|
2/12/2025
|
—
|
—
|
8,300
(8)
|
$56,191
|
|
|
Glenn M. Farrell
|
2015
|
—
|
86,000
(3)
|
—
|
$8.50
|
2/12/2025
|
—
|
—
|
11,000
(8)
|
$74,470
|
|
Claudia J. Merkle
|
2012
|
12,000
|
—
|
—
|
$10.00
|
5/30/2022
|
—
|
—
|
—
|
$—
|
|
2012
|
12,000
|
—
|
—
|
$10.00
|
11/7/2022
|
—
|
—
|
4,445
(5)
|
$30,093
|
|
|
2013
|
20,166
|
10,081
(1)
|
—
|
$11.75
|
2/14/2023
|
—
|
—
|
—
|
$—
|
|
|
2014
|
25,333
|
50,667
(2)
|
—
|
$12.32
|
2/12/2024
|
—
|
—
|
6,334
(7)
|
$42,881
|
|
|
2015
|
—
|
86,200
(3)
|
—
|
$8.50
|
2/12/2025
|
—
|
—
|
9,000
(8)
|
$60,930
|
|
|
(1)
|
Remaining stock options scheduled to vest 100% on 2/14/2016.
|
|
(2)
|
Remaining stock options scheduled to vest 50% on 2/12/2016 and 50% on 2/12/2017.
|
|
(3)
|
Stock options scheduled to vest in thirds on 2/12/2016, 2/12/2017 and 2/12/2018.
|
|
(4)
|
Remaining stock options scheduled to vest 50% on 9/10/2016 and 50% on 9/10/2017.
|
|
(5)
|
The shares underlying the RSUs are scheduled to vest based on the achievement of stock-price performance conditions (the performance shares). The performance shares are scheduled to vest in 1/2 increments in the event that the Company achieves a stock price of $14.00 and $16.00, in each case, during any 30-day trading period.
|
|
(6)
|
Remaining RSUs scheduled to vest 100% on 2/14/2016.
|
|
(7)
|
Remaining RSUs scheduled to vest 50% on 2/12/2016 and 50% on 2/12/2017.
|
|
(8)
|
RSUs scheduled to vest in thirds on 2/12/2016, 2/12/2017 and 2/12/2018.
|
|
(9)
|
Remaining RSUs scheduled to vest 50% on 9/10/2016 and 50% on 9/10/2017.
|
|
(10)
|
The payout value is based on the $6.77 closing price of our common stock on NASDAQ on December 31, 2015 multiplied by the number of unvested RSUs as of December 31, 2015.
|
|
Name
|
Scenario
|
Cash Severance ($)
|
Stock Option Vesting ($)
|
Restricted Stock Unit Vesting ($)
|
Benefits ($)
|
Total ($)
|
|
Bradley M. Shuster
|
Voluntary Resignation (no Good Reason)
|
- (1)
|
-
|
-
|
- (2)
|
-
|
|
Termination without Cause or for Good Reason
|
$1,200,000 (3)
|
- (4)
|
$605,238 (5)
|
- (2)
|
$1,805,238
|
|
|
Involuntary Termination for Cause
|
- (1)
|
-
|
-
|
- (2)
|
-
|
|
|
Termination Following Change in Control
|
$2,400,000 (6)
|
- (7)
|
$605,238 (8)
|
- (2)
|
$3,005,238
|
|
|
No Termination Following Change in Control
|
-
|
- (7)
|
$605,238 (8)
|
-
|
$605,238
|
|
|
William J. Leatherberry
|
Voluntary Resignation (no Good Reason)
|
-
|
-
|
-
|
-
|
-
|
|
Termination without Cause or for Good Reason
|
-
|
- (9)
|
-
|
-
|
-
|
|
|
Involuntary Termination for Cause
|
-
|
-
|
-
|
-
|
-
|
|
|
Termination Following Change in Control
|
$940,624 (10)
|
- (7)
|
$92,031 (8)
|
-
|
$1,032,655
|
|
|
No Termination Following Change in Control
|
-
|
- (7)
|
$92,031 (8)
|
-
|
$92,031
|
|
|
Glenn M. Farrell
|
Voluntary Resignation (no Good Reason)
|
-
|
-
|
-
|
-
|
-
|
|
Termination without Cause or for Good Reason
|
-
|
- (9)
|
-
|
-
|
-
|
|
|
Involuntary Termination for Cause
|
-
|
-
|
-
|
-
|
-
|
|
|
Termination Following Change in Control
|
$984,375 (10)
|
- (7)
|
$74,470 (8)
|
-
|
$1,058,845
|
|
|
No Termination Following Change in Control
|
-
|
- (7)
|
$74,470 (8)
|
-
|
$74,470
|
|
|
Claudia J. Merkle
|
Voluntary Resignation (no Good Reason)
|
-
|
-
|
-
|
-
|
-
|
|
Termination without Cause or for Good Reason
|
-
|
- (9)
|
-
|
-
|
-
|
|
|
Involuntary Termination for Cause
|
-
|
-
|
-
|
-
|
-
|
|
|
Termination Following Change in Control
|
-
|
- (7)
|
$103,811 (8)
|
-
|
$103,811
|
|
|
No Termination Following Change in Control
|
-
|
- (7)
|
$103,811 (8)
|
-
|
$103,811
|
|
|
(1)
|
Under the terms of Mr. Shuster's employment agreement, he would be entitled to be paid any Accrued Compensation.
|
|
(2)
|
Under the terms of Mr. Shuster's employment agreement, he would be entitled to be paid any Accrued Benefits.
|
|
(3)
|
As provided in Mr. Shuster's employment agreement, amount is equal to the sum of (1) any Accrued Compensation and (2) the sum of one times his 2015 annual base salary and one times his 2015 target annual bonus, which is 100% of the annual base salary.
|
|
(4)
|
Upon a termination of employment without "cause" or for "good reason," any outstanding stock options that were not then exercisable and vested would have become fully exercisable and vested at the date of such termination. The exercise prices of all outstanding stock options as of December 31, 2015 were in excess of the closing price of our common stock on December 31, 2015. Accordingly, no value is listed in this table in respect of accelerated stock option vesting assuming a termination on December 31, 2015.
|
|
(5)
|
With a termination of employment without "cause" or for "good reason," unvested time-vested shares would have become fully vested at the date of termination and unvested performance shares would have remained outstanding and subject to vesting upon the achievement of the applicable stock price goals.
|
|
(6)
|
As provided in Mr. Shuster's employment agreement, amount includes two times the sum of (i) Mr. Shuster's 2015 annual base salary plus (ii) his 2015 target annual bonus, which is 100% of the annual base salary.
|
|
(7)
|
Upon a change in control, any outstanding stock options that were not then exercisable and vested would have become fully exercisable and vested as of the date of such change in control. The exercise prices of all outstanding stock options as of December 31, 2015 were in excess of the closing price of our common stock on December 31, 2015. Accordingly, no value is listed in this table in respect of accelerated stock option vesting assuming a change in control on December 31, 2015.
|
|
(8)
|
Upon a change in control, unvested time-vested shares would have become fully vested and our Compensation Committee would thereafter determine whether any outstanding performance shares held by certain named executive officers would vest based on the attainment of the stock price goals at the time of the change in control.
|
|
(9)
|
With a termination of employment without "cause" or for "good reason," a prorated portion of the executive's outstanding stock options that were not then exercisable and vested would have become fully exercisable and vested at the date of termination. The exercise prices of all outstanding stock options as of December 31, 2015 were in excess of the closing price of our common stock on December 31, 2015. Accordingly, no value is listed in this table in respect of accelerated stock option vesting assuming a termination on December 31, 2015.
|
|
(10)
|
As provided in Messrs. Farrell's and Leatherberry's respective offer letters, amount includes one and a half times the sum of the (i) executive's 2015 annual base salary plus (ii) the executive's 2015 target annual bonus, which is 75% of the annual base salary.
|
|
|
Fees earned or paid in cash
|
Stock awards
|
Total
|
|
Name
|
($)
|
($)
(3)
|
($)
|
|
Michael Embler
(1)
|
$65,000
|
$49,997
|
$114,997
|
|
James G. Jones
(1)
|
$65,000
|
$49,997
|
$114,997
|
|
Michael Montgomery
(1)
|
$65,000
|
$49,997
|
$114,997
|
|
John Brandon Osmon
(1)
|
$65,000
|
$49,997
|
$114,997
|
|
James H. Ozanne
(2)
|
$65,000
|
$49,997
|
$114,997
|
|
Steven L. Scheid
(2)
|
$65,000
|
$49,997
|
$114,997
|
|
•
|
each person known to us to be the beneficial owner of more than five percent of our Class A common stock;
|
|
•
|
each named executive officer;
|
|
•
|
each of our directors; and
|
|
•
|
all of our current executive officers, identified above under the caption "
Executive Officers,
" and directors as a group.
|
|
|
Shares of Class A Common
Stock Beneficially Owned
|
|
|
|
Number
|
%
|
|
Named Executive Officers and Directors:
|
|
|
|
Bradley M. Shuster
(1)
|
1,726,276
|
2.9%
|
|
William J. Leatherberry
(2)
|
98,230
|
*
|
|
Glenn M. Farrell
(3)
|
50,727
|
*
|
|
Claudia J. Merkle
(4)
|
142,346
|
*
|
|
John Brandon Osmon
(5)
|
7,449,145
|
12.6%
|
|
James H. Ozanne
(6)
|
174,923
|
*
|
|
Steven L. Scheid
(7)
|
149,485
|
*
|
|
Michael Embler
(8)
|
103,676
|
*
|
|
James G. Jones
(9)
|
177,676
|
*
|
|
Michael Montgomery
(10)
|
43,958
|
*
|
|
All executive officers and directors as a group (11 persons)
|
10,266,184
|
16.9%
|
|
*
|
Represents less than 1% beneficial ownership.
|
|
(1)
|
Represents 246,378 shares held directly, 250,000 shares held indirectly in the Shuster Family Trust, of which Mr. Shuster and his wife are co-trustees and beneficiaries, and 1,229,898 vested stock options.
|
|
(2)
|
Represents 36,881 shares held directly, 10,000 shares held indirectly by Mr. Leatherberry's spouse and 51,349 vested stock options.
|
|
(3)
|
Represents 22,061 shares held directly and 28,666 vested stock options.
|
|
(4)
|
Represents 8,700 shares held directly and 133,646 vested stock options.
|
|
(5)
|
Represents 39,832 shares held directly, 37,813 vested stock options and 7,371,500 shares held by Hayman Capital Master Fund, LP (HCMF). Mr. Osmon is a managing director of Hayman Capital Management, L.P. (Hayman Capital) and is a director of the Company. Hayman Capital acts as an investment adviser to, and manages investment and trading accounts of, other persons, including HCMF. Hayman Investments, L.L.C. (Hayman Investments) is the general partner of Hayman Capital. J. Kyle Bass is the managing member of Hayman Investments. In the foregoing capacities, Hayman Investments and Mr. Bass may be deemed to beneficially own securities beneficially owned by Hayman Capital. In connection with Mr. Osmon's employment by Hayman Capital, securities of the Company held by Mr. Osmon may be deemed to be beneficially owned by HCMF. All other securities of the Company reported herein are held for the account of HCMF. Each of the foregoing has disclaimed beneficial ownership of the securities except to the extent of his or its pecuniary interest in such securities.
|
|
(6)
|
Represents 63,267 shares held directly (including 10,000 shares held in the James H. Ozanne Revocable Trust of which Mr. Ozanne is the sole trustee and beneficiary), 10,000 shares held in the Susan A. Ozanne Family Trust of which Mr. Ozanne and his wife are co-trustees and beneficiaries, 20,000 shares held by Greenrange Partners LLC, a venture capital investment company for which Mr. Ozanne serves as principal, 75,625 vested stock options and 6,031 RSUs expected to vest within 60 days of March 29, 2016.
|
|
(7)
|
Represents 57,829 shares held directly, 10,000 shares held in the Scheid Family Trust of which Mr. Scheid and his wife are co-trustees and beneficiaries, 75,625 vested stock options and 6,031 RSUs expected to vest within 60 days of March 29, 2016.
|
|
(8)
|
Represents 59,832 shares held directly, 37,813 vested stock options and 6,031 RSUs expected to vest within 60 days of March 29, 2016.
|
|
(9)
|
Represents 66,832 shares held directly, 57,000 shares held in the James G. Jones and Maria F. Jones Revocable Trust, 10,000 shares held by the Jennie K. Jones Irrevocable Living Trust, of which Mr. Jones is the sole trustee, 37,813 vested stock options and 6,031 RSUs expected to vest within 60 days of March 29, 2016.
|
|
(10)
|
Represents 6,145 shares held directly and 37,813 vested stock options.
|
|
Greater than 5% Stockholders, as of March 29, 2016
|
Number
|
%
|
|
Hayman Capital Management, L.P.
(1)
|
7,371,500
|
12.5%
|
|
Oaktree Capital Management LP
(2)
|
5,816,443
|
9.9%
|
|
Claren Road Asset Management, LLC
(3)
|
3,000,000
|
5.1%
|
|
Long Pond Capital, LP
(4)
|
3,370,172
|
5.7%
|
|
CI Investments Inc.
(5)
|
2,963,479
|
5.0%
|
|
(1)
|
Based on a Schedule 13D filed with the SEC on November 8, 2013, as amended by a Schedule 13D filed with the SEC on August 5, 2015, and a Form 4 filed with the SEC on November 10, 2015. Hayman Capital, Hayman Investments and Mr. Bass report that they beneficially own 7,371,500 shares of our common stock, with shared voting and dispositive power. Hayman Capital acts as an investment adviser to, and manages investment and trading accounts of, other persons, including HCMF. All securities of the Company reported in this table for this stockholder are held for the account of HCMF. Hayman Investments is the general partner of Hayman Capital. Mr. Bass is the managing member of Hayman Investments. In the foregoing capacities, Hayman Investments and Mr. Bass may be deemed to beneficially own securities beneficially owned by Hayman Capital. Mr. Osmon is a managing director of Hayman Capital and is a director of the Company and as such has received stock options, RSUs and phantom stock, all of which are subject to vesting schedules and were granted pursuant to equity incentive plans adopted by the Company. Mr. Osmon's beneficial ownership is shown in the table above reporting beneficial ownership of our named executive officers and directors. In connection with Mr. Osmon's employment by Hayman Capital, HCMF may be deemed to beneficially own securities of the Company beneficially owned by Mr. Osmon. Each of the foregoing has disclaimed beneficial ownership of the securities except to the extent of his or its pecuniary interest in such securities. The address of the principal business office for Hayman Capital, HCMF, Hayman Investments and Mr. Bass is 2101 Cedar Springs Drive, Suite 1400, Dallas, Texas, 75201.
|
|
(2)
|
Based on a Schedule 13G/A filed with the SEC on February 11, 2016. The number of shares reported includes: (a) 5,681,992 shares over which Oaktree Value Equity Holdings, L.P. (VE Holdings) has sole voting and dispositive power and (b) 134,451 shares over which Oaktree Value Equity Fund-SP, L.P. (VEF-SP) has sole voting and dispositive power. The general partner of VE Holdings is Oaktree Value Equity Fund GP, L.P. (VEF GP). The general partner of VEF GP is Oaktree Value Equity Fund GP Ltd (VEF Ltd.). The general partner of VEF-SP is Oaktree Value Equity Fund-SP GP, L.P. (VEF-SP GP). The sole director of VEF Ltd. and the general partner of VEF-SP GP is Oaktree Capital Management, L.P. (Management). The general partner of Management is Oaktree Holdings, Inc. (Holdings). The sole shareholder of VEF Ltd. is Oaktree Fund GP I, L.P. (GP I). The general partner of GP I is Oaktree Capital I, L.P. (Capital I). The general partner of Capital I is OCM Holdings I, LLC (Holdings I). The managing member of Holdings I is Oaktree Holdings, LLC (Holdings LLC). The sole shareholder of Holdings and the managing member of Holdings LLC is Oaktree Capital Group, LLC, (OCG). The duly elected manager of OCG is Oaktree Capital Group Holdings GP, LLC. The principal business address for each of the above entities is 333 S. Grand Avenue, 28th Floor, Los Angeles, CA 90071.
|
|
(3)
|
Based on a Schedule 13G/A filed with the SEC on February 16, 2016. Claren Road Asset Management, LLC (Claren Road) reports that these securities are held by Claren Road Credit Opportunities Master Fund, Ltd. (Claren Road Credit Opportunities Master) and Claren Road Credit Master Fund, Ltd. (Claren Road Credit Master and together with Claren Road Credit Opportunities Master, the Claren Road Funds). Claren Road serves as investment manager for the Claren Road Funds and shares voting and dispositive power over the shares held by the applicable Claren Road Fund. Investment and voting decisions have been delegated to Messrs. Brian Riano, Sean Fahey, John Eckerson and Albert Marino, members of Claren Road. Claren Road Credit Master has disclaimed beneficial ownership of these shares. The address of Claren Road and the Claren Road Funds is 51 Astor Place, 12th Floor, New York, NY 10003.
|
|
(4)
|
Based a Schedule 13G filed with the SEC on February 12, 2016. The number of shares reported is 3,370,172. The shares were purchased by Long Pond Capital, LP (Long Pond LP) through the accounts of certain private funds (collectively the Funds) for which Long Pond LP acts as the investment manager. Long Pond Capital GP, LLC (Long Pond LLC) serves as the general partner of Long Pond LP and shares beneficial ownership and dispositive power of the Funds with Long Pond LP and its principal, John Khoury. The address of the principal business office for Long Pond LP, Long Pond LLC and John Khoury is 527 Madison Avenue, 15th Floor, New York, New York 10022.
|
|
(5)
|
Based on a Schedule 13G filed with the SEC on January 29, 2016. The number of shares reported is 2,963,479. CI Investments Inc. reports that it and Signature Global Asset Management, an internal business unit of CI Investments Inc., beneficially own these shares and share voting and dispositive power. The address of CI Investments Inc. is 2 Queen Street East, 20th Floor, Toronto, Ontario, Canada, M5C 3G7.
|
|
Plan Category
|
Number of securities to be issued upon exercise of outstanding options, warrants, and rights (2)
|
Weighted-average exercise price of outstanding options, warrants, and rights (3)
|
Number of securities remaining available for future issuance under equity compensation plans (4)
|
|||
|
Equity compensation plans approved by security holders (1)
|
5,294,592
|
|
$10.21
|
3,313,798
|
|
|
|
Equity compensation plans not approved by security holders
|
—
|
|
—
|
|
—
|
|
|
Total
|
5,294,592
|
|
$10.21
|
3,313,798
|
|
|
|
(1)
|
NMI 2012 Stock Incentive Plan (2012 Plan) and NMI 2014 Omnibus Incentive Plan (2014 Plan).
|
|
(2)
|
Includes 3,061,993 and 789,283 shares to be issued upon exercise of outstanding stock options under the 2012 and 2014 Plans, respectively and 696,848 and 746,468 shares of unvested RSUs granted under the 2012 and 2014 Plans, respectively.
|
|
(3)
|
Weighted-average exercise price is based solely on outstanding options.
|
|
(4)
|
The amount shown represents 849,549 shares reserved for issuance under the 2012 Plan and 2,464,249 shares reserved for issuance under the 2014 Plan.
|
|
|
2015
|
|
2014
|
||||
|
Audit Fees
|
$
|
516,895
|
|
|
$
|
518,883
|
|
|
Audit-Related Fees
|
—
|
|
|
—
|
|
||
|
Tax Fees
|
—
|
|
|
—
|
|
||
|
All Other Fees
|
—
|
|
|
—
|
|
||
|
Total Fees
|
$
|
516,895
|
|
|
$
|
518,883
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|